New York Certifies Verinata's Lab, Paving Way for Firm to Offer Verifi NIPD in All 50 States | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina announced late Thursday that Verinata Health has received a clinical laboratory permit from the State of New York for its laboratory, allowing the company to market its Verifi non-invasive prenatal diagnostic test in the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.